Akoya: New products and partnerships further accelerate and simplify identification of actionable spatial signatures, creating unprecedented opportunities to improve patient outcomes Ready-to-use panels, turnkey software

[#item_full_content] Reposted from : [#item_link]

Visiopharm today announces that it will be entering into a research pilot with Massachusetts General Hospital (MGH) to investigate the use of AI-powered precision pathology

EVIDENT and Ultivue: Collaboration provides a convenient, fast tool for multiplexed immunofluorescence imaging in translational studies. WALTHAM and CAMBRIDGE, Mass., (Nov. 7, 2022)–Evident Corporation, a

Queen Mary University of London has become the first university outside of North America to acquire a Cell DIVE imager, providing access to the latest

by Tim Scherr, Johannes Seiffarth, Bastian Wollenhaupt, Oliver Neumann, Marcel P. Schilling, Dietrich Kohlheyer, Hanno Scharr, Katharina N?h, Ralf Mikut In biotechnology, cell growth is

Pixelgen Technologies has emerged from stealth with a mission to bring a new dimension to single-cell spatial proteomics. The launch follows the close of an

SAN DIEGO, Nov. 8, 2022 /PRNewswire/ — Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc.,

Carl Zeiss Microscopy, LLC, has announced that it has entered into an agreement with Ultivue Inc. to co-market Ultivue’s multiplex biomarker assays for tissue phenotyping

Deep Bio, a leading AI biotech dedicated to cancer diagnosis, and Visiopharm, a world leader in AI-powered image analysis and tissue mining for research and